Latest News & Features
Patents
Korean pharmaceutical, biotech, and life sciences companies are actively expanding globally, leading to more complex and multifaceted IP strategies than in the past. 29 October 2024
Patents
How to foster effective collaboration between academia and industry?
Best practices for bridging that gap between the two spheres
Technology transfer
How to leverage academic research for commercialization 29 October 2024
Patents
The patent landscape for biologics, biosimilars, and advanced therapeutic antibodies is undergoing rapid change, presenting both opportunities and challenges for innovators and manufacturers. This panel will explore current issues and strategies in this dynamic field. 29 October 2024
Patents
In this session, Will James and Tim Harris will discuss their personal experiences litigating life sciences cases before the UPC. They will share their substantive and procedural insights, as well as strategic considerations and pitfalls to avoid. 29 October 2024
Patents
Long-recognised, unwritten jurisdictional norms have seen questions of validity and infringement of registered IP rights reserved to the courts of the country of registration. 29 October 2024
Patents
Patents are key to ensuring continued investment in pharma R&D.
What are the unique patent considerations for pharma/biotech patents and AI patents in Europe? 29 October 2024
Patents
In the world of intellectual property, securing patents for innovative ideas rests heavily on the criteria of novelty, non-obviousness, and the inventive step. 29 October 2024
Patents
In today's global marketplace, intellectual property (IP) rights are not merely legal tools but strategic assets that can significantly influence a product's lifecycle, from development to market. 29 October 2024
Patents
In an incredibly competitive and complex landscape, intellectual property is a critical asset for pharmaceutical and biotech companies. 29 October 2024
Patents
Machine learning can be an invaluable tool in drug discovery for target identification, compound screening, and predictive modeling. The use of AI can accelerate drug discovery timelines, reduce costs and enhance therapeutic outcomes. 29 October 2024
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.